IDH3A and central nervous system cancer: Isocitrate dehydrogenase (IDH) mutant oncogenes, which are found in the progression of lower-grade gliomas to higher-grade gliomas, are almost completely absent from patient-derived lines, thus prompting efforts to exogenously express these oncogenes in IDH wild-type tumor lines.